Newsroom

Newsroom

Press Releases

1 of 1

Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation
August 17, 2025
Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand
July 22, 2025
Waldencast Reports Q1 2025 Financial Results
May 12, 2025
Waldencast plc Announces First Quarter Fiscal 2025 Results Conference Call and Webcast
May 5, 2025
Waldencast Reports Q4 2024 and Fiscal Year 2024 Financial Results
March 17, 2025
Waldencast plc Announces Fourth Quarter and Fiscal Year 2024 Results Conference Call and Webcast
March 10, 2025

Media Library

1 of 1